Endocrinology, Vol 133, 461-466, Copyright © 1993 by Endocrine Society

ARTICLES

Parastatin (porcine chromogranin A347-419), a novel chromogranin A- derived peptide, inhibits parathyroid cell secretion

BH Fasciotto, CA Trauss, GH Greeley and DV Cohn
Department of Biology, University of Louisville, Kentucky 40292.

Chromogranin A (CgA), previously referred to as secretory protein-I, is a 50-kilodalton protein present in secretory granules of many endocrine and neuroendocrine cells. In the parathyroid it is present and cosecreted with PTH in response to hypocalcemia. CgA appears to be a precursor of bioactive peptides including pancreastatin, beta-granin, vasostatin, and chromostatin. The presence of several highly conserved pairs of basic amino acids, putative cleavage sites, in the CgA molecule suggests that other yet unidentified bioactive peptides might exist within the molecule. We tested this speculation by subjecting porcine parathyroid CgA to digestion by endoproteinase Lys-C. Resulting CgA-derived peptides were isolated by reverse-phase C18 HPLC and tested for their ability to affect low-Ca2+ stimulated secretion by porcine parathyroid cells. We characterized one peptide, which we named parastatin, that inhibited secretion of both PTH and CgA in a dose- dependent fashion over the range of 0.2-0.6 microM. Parastatin migrated as a single band on sodium dodecyl sulfate-polyacrylamide gel electrophoresis with an apparent mol wt of 11,000. Edman degradation yielded the sequence L-S-F-R-A-P-A-Y-G-F-R-G-P-G-L corresponding to residues 347-361 of porcine CgA. Amino acid analysis of endoproteinase Lys-C and endoproteinase Asp-N-generated fragments indicated that parastatin corresponds to residues 347-419 of CgA. A synthetic NH2- terminal fragment of rat parastatin corresponding to residues 1-19 was an inhibitory as intact porcine parastatin on parathyroid gland secretion. These results extend the concept that CgA is a precursor of biologically active peptides.

This article has been cited by other articles:

				G. M. Schmid, P. Meda, D. Caille, E. Wargent, J. O'Dowd, D. F. Hochstrasser, M. A. Cawthorne, and J.-C. Sanchez Inhibition of Insulin Secretion by Betagranin, an N-terminal Chromogranin A Fragment J. Biol. Chem., April 27, 2007; 282(17): 12717 - 12724. [Abstract] [Full Text] [PDF]

				C.-u. Choe and B. E. Ehrlich The Inositol 1,4,5-Trisphosphate Receptor (IP3R) and Its Regulators: Sometimes Good and Sometimes Bad Teamwork Sci. Signal., November 28, 2006; 2006(363): re15 - re15. [Abstract] [Full Text] [PDF]

				G. N. Hendy, T. Li, M. Girard, R. C. Feldstein, S. Mulay, R. Desjardins, R. Day, A. C. Karaplis, M. L. Tremblay, and L. Canaff Targeted Ablation of the Chromogranin A (Chga) Gene: Normal Neuroendocrine Dense-Core Secretory Granules and Increased Expression of Other Granins Mol. Endocrinol., August 1, 2006; 20(8): 1935 - 1947. [Abstract] [Full Text] [PDF]

				T. A. Greenwood, F. Rao, M. Stridsberg, N. R. Mahapatra, M. Mahata, E. O. Lillie, S. K. Mahata, L. Taupenot, N. J. Schork, and D. T. O'Connor Pleiotropic effects of novel trans-acting loci influencing human sympathochromaffin secretion Physiol Genomics, May 16, 2006; 25(3): 470 - 479. [Abstract] [Full Text] [PDF]

				J. R. Peinado, R. Vazquez-Martinez, D. Cruz-Garcia, A. Ruiz-Navarro, Y. Anouar, M. C. Tonon, H. Vaudry, F. Gracia-Navarro, J. P. Castano, and M. M. Malagon Differential Expression and Processing of Chromogranin A and Secretogranin II in Relation to the Secretory Status of Endocrine Cells Endocrinology, March 1, 2006; 147(3): 1408 - 1418. [Abstract] [Full Text] [PDF]

				D. T. O'Connor, P. E. Cadman, C. Smiley, R. M. Salem, F. Rao, J. Smith, S. D. Funk, S. K. Mahata, M. Mahata, G. Wen, et al. Pancreastatin: Multiple Actions on Human Intermediary Metabolism in Vivo, Variation in Disease, and Naturally Occurring Functional Genetic Polymorphism J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5414 - 5425. [Abstract] [Full Text] [PDF]

				C.-U. Choe, K. D. Harrison, W. Grant, and B. E. Ehrlich Functional Coupling of Chromogranin with the Inositol 1,4,5-Trisphosphate Receptor Shapes Calcium Signaling J. Biol. Chem., August 20, 2004; 279(34): 35551 - 35556. [Abstract] [Full Text] [PDF]

				L. Taupenot, K. L. Harper, and D. T. O'Connor The Chromogranin-Secretogranin Family N. Engl. J. Med., March 20, 2003; 348(12): 1134 - 1149. [Full Text] [PDF]

				C. Ceconi, R. Ferrari, T. Bachetti, C. Opasich, M. Volterrani, B. Colombo, G. Parrinello, and A. Corti Chromogranin A in heart failure. A novel neurohumoral factor and a predictor for mortality Eur. Heart J., June 2, 2002; 23(12): 967 - 974. [Abstract] [Full Text] [PDF]

				E. C. Thrower, H. Y. Park, S. H. So, S. H. Yoo, and B. E. Ehrlich Activation of the Inositol 1,4,5-Trisphosphate Receptor by the Calcium Storage Protein Chromogranin A J. Biol. Chem., May 3, 2002; 277(18): 15801 - 15806. [Abstract] [Full Text] [PDF]

				G. M. Portela–Gomes and M. Stridsberg Selective Processing of Chromogranin A in the Different Islet Cells in Human Pancreas J. Histochem. Cytochem., April 1, 2001; 49(4): 483 - 490. [Abstract] [Full Text]

				V. Turquier, H. Vaudry, S. Jégou, and Y. Anouar Frog Chromogranin A Messenger Ribonucleic Acid Encodes Three Highly Conserved Peptides. Coordinate Regulation of Proopiomelanocortin and Chromogranin A Gene Expression in the Pars Intermedia of the Pituitary During Background Color Adaptation Endocrinology, September 1, 1999; 140(9): 4104 - 4112. [Abstract] [Full Text]

				P. Gadroy, M. Stridsberg, C. Capon, J.-C. Michalski, J.-M. Strub, A. Van Dorsselaer, D. Aunis, and M.-H. Metz-Boutigue Phosphorylation and O-Glycosylation Sites of Human Chromogranin A (CGA79-439) from Urine of Patients with Carcinoid Tumors J. Biol. Chem., December 18, 1998; 273(51): 34087 - 34097. [Abstract] [Full Text] [PDF]

				J. Ciesielski-Treska, G. Ulrich, L. Taupenot, S. Chasserot-Golaz, A. Corti, D. Aunis, and M.-F. Bader Chromogranin A Induces a Neurotoxic Phenotype in Brain Microglial Cells J. Biol. Chem., June 5, 1998; 273(23): 14339 - 14346. [Abstract] [Full Text] [PDF]

				E. Soliman, L. Canaff, J. Fox, and G. N. Hendy In Vivo Regulation of Chromogranin A Messenger Ribonucleic Acid in the Parathyroid by 1,25-Dihydroxyvitamin D: Studies in Normal Rats and in Chronic Renal Insufficiency Endocrinology, June 1, 1997; 138(6): 2596 - 2600. [Abstract] [Full Text] [PDF]

				J.-M. Strub, O. Sorokine, A. Van Dorsselaer, D. Aunis, and M.-H. Metz-Boutigue Phosphorylation and O-Glycosylation Sites of Bovine Chromogranin A from Adrenal Medullary Chromaffin Granules and Their Relationship with Biological Activities J. Biol. Chem., May 2, 1997; 272(18): 11928 - 11936. [Abstract] [Full Text] [PDF]

				J.-M. Strub, Y. Goumon, K. Lugardon, C. Capon, M. Lopez, M. Moniatte, A. Van Dorsselaer, D. Aunis, and M.-H. Metz-Boutigue Antibacterial Activity of Glycosylated and Phosphorylated Chromogranin A-derived Peptide 173-194 from Bovine Adrenal Medullary Chromaffin Granules J. Biol. Chem., November 8, 1996; 271(45): 28533 - 28540. [Abstract] [Full Text] [PDF]

				C. V. Taylor, L. Taupenot, S. K. Mahata, M. Mahata, H. Wu, S. Yasothornsrikul, T. Toneff, C. Caporale, Q. Jiang, R. J. Parmer, et al. Formation of the Catecholamine Release-inhibitory Peptide Catestatin from Chromogranin A. DETERMINATION OF PROTEOLYTIC CLEAVAGE SITES IN HORMONE STORAGE GRANULES J. Biol. Chem., July 21, 2000; 275(30): 22905 - 22915. [Abstract] [Full Text] [PDF]

				J. Ciesielski-Treska, G. Ulrich, S. Chasserot-Golaz, J. Zwiller, M.-O. Revel, D. Aunis, and M.-F. Bader Mechanisms Underlying Neuronal Death Induced by Chromogranin A-activated Microglia J. Biol. Chem., April 13, 2001; 276(16): 13113 - 13120. [Abstract] [Full Text] [PDF]

				Q. Jiang, L. Taupenot, S. K. Mahata, M. Mahata, D. T. O'Connor, L. A. Miles, and R. J. Parmer Proteolytic Cleavage of Chromogranin A (CgA) by Plasmin. SELECTIVE LIBERATION OF A SPECIFIC BIOACTIVE CgA FRAGMENT THAT REGULATES CATECHOLAMINE RELEASE J. Biol. Chem., June 29, 2001; 276(27): 25022 - 25029. [Abstract] [Full Text] [PDF]